Literature DB >> 11184795

Optimal health insurance: the case of observable, severe illness.

M E Chernew1, W E Encinosa, R A Hirth.   

Abstract

We explore optimal cost-sharing provisions for insurance contracts when individuals have observable, severe diseases with a discrete number of medically appropriate treatment options. Variation in preferences for alternative treatments is unobserved by the insurer and non-contractible. Interest in such situations is increasingly common, exemplified by disease carve-out programs and shared decision-making (SDM) tools. We demonstrate that optimal insurance charges a copay to patients choosing the high-cost treatment and provides consumers of the low-cost treatment a cash payment. A simulation of the effect of such a policy, based on prostate cancer, indicates a substantial reduction in moral hazard.

Entities:  

Mesh:

Year:  2000        PMID: 11184795     DOI: 10.1016/s0167-6296(00)00061-8

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  6 in total

1.  A game-theoretic framework for estimating a health purchaser's willingness-to-pay for health and for expansion.

Authors:  Reza Yaesoubi; Stephen D Roberts
Journal:  Health Care Manag Sci       Date:  2010-08-12

2.  Price vs. quantity in health insurance reimbursement.

Authors:  Francesca Barigozzi
Journal:  Int J Health Care Finance Econ       Date:  2006-10-07

3.  A systematic review of strategies used for controlling consumer moral hazard in health systems.

Authors:  Zohreh Koohi Rostamkalaee; Mehdi Jafari; Hasan Abolghasem Gorji
Journal:  BMC Health Serv Res       Date:  2022-10-18       Impact factor: 2.908

Review 4.  Demand-side Interventions to Control Moral Hazard in Health Systems, Beneficial or Detrimental: A Systematic Review Study.

Authors:  Zohreh Koohi Rostamkalaee; Mehdi Jafari; Hasan Abolghasem Gorji
Journal:  Med J Islam Repub Iran       Date:  2022-06-27

5.  Paying on the margin for medical care: Evidence from breast cancer treatments.

Authors:  Liran Einav; Amy Finkelstein; Heidi Williams
Journal:  Am Econ J Econ Policy       Date:  2016-02

6.  Distinguishing moral hazard from access for high-cost healthcare under insurance.

Authors:  Christopher T Robertson; Andy Yuan; Wendan Zhang; Keith Joiner
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.